News
Merck is undergoing a strategic restructuring, resulting in immediate job cuts in administration, sales, and research as part of a plan to save $3 billion by 2027.
Along with its financial results for the second quarter of 2025, Merck revealed a restructuring plan to save $3 billion by ...
The scale of the Merck layoffs has not been revealed, but the company indicated that it would target roles in the ...
Merck said it is embarking on a multi-year cost-savings plan, which includes cuts to its workforce and real-estate footprint, ...
Merck & Co. Inc. (NYSE:MRK) shares fell over 6% in early trading Tuesday after the pharmaceutical giant reported a mixed ...
The restructuring includes the elimination of certain roles and a reduction in the company’s global real estate footprint.
Dive Brief: Merck is constructing a $1 billion drug manufacturing facility in Wilmington, Delaware, as part of its commitment to investment and growth in the United States. The company on Tuesday ...
Merck (NYSE: MRK) has broken ground on a $1 billion facility in Wilmington, Delaware, becoming the latest pharmaceutical company to boost domestic investment as industry-targeted tariffs loom.
Merck Animal Health To Invest $895M To Expand Production, R&D In Kansas A new manufacturing plant in De Soto will be a Center of Excellence for the global company, along with expanded R&D ...
Merck is seeking confirmation that Bayer is liable for talc claims that have been filed against both companies since 2014 when Bayer bought product lines from Merck in a $14 billion deal. The ...
Merck & Co., Inc. (NYSE:MRK) ranks among the best magic formula stocks to invest in. On July 10, UBS reiterated its Buy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback